Works by Gururangan, Sridharan

Results: 59

Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.

Published in:

Psycho-Oncology, 2008, v. 17, n. 11, p. 1157, doi. 10.1002/pon.1349

By:

Hardy, Kristina K.;
Bonner, Melanie J.;
Willard, Victoria W.;
Watral, Melody Ann;
Gururangan, Sridharan

Publication type:

Article

Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 12, p. 1589, doi. 10.1007/s00262-017-2051-6

By:

Gururangan, Sridharan;
Reap, Elizabeth;
Schmittling, Robert;
Kocak, Mehmet;
Reynolds, Renee;
Grant, Gerald;
Onar-Thomas, Arzu;
Baxter, Patricia;
Pollack, Ian;
Phillips, Peter;
Boyett, James;
Fouladi, Maryam;
Mitchell, Duane

Publication type:

Article

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.

Published in:

Neuro-Oncology, 2004, v. 6, n. 2, p. 145, doi. 10.1215/S1152851703000498

By:

Quinn, Jennifer A.;
Reardon, David A.;
Friedman, Allan H.;
Rich, Jeremy N.;
Sampson, John H.;
Vredenburgh, James;
Gururangan, Sridharan;
Provenzale, James M.;
Walker, Amy;
Schweitzer, Holly;
Bigner, Darell D.;
Tourt-Uhlig, Sandra;
Herndon II, James E.;
Affronti, Mary Lou;
Jackson, Susanne;
Allen, Deborah;
Ziegler, Karen;
Bohlin, Cindy;
Lentz, Christy;
Friedman, Henry S.

Publication type:

Article

Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.

Published in:

Neuro-Oncology, 2004, v. 6, n. 2, p. 134, doi. 10.1215/S1152851703000413

By:

Reardon, David A.;
Quinn, Jennifer A.;
Rich, Jeremy N.;
Gururangan, Sridharan;
Vredenburgh, James;
Sampson, John H.;
Provenzale, James M.;
Walker, Amy;
Badruddoja, Michael;
Tourt-Uhlig, Sandra;
Herndon II, James E.;
Dowell, Jeannette M.;
Affronti, Mary Lou;
Jackson, Susanne;
Allen, Deborah;
Ziegler, Karen;
Silverman, Steven;
Bohlin, Cindy;
Friedman, Allan H.;
Bigner, Darell D.

Publication type:

Article

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

Published in:

2013

By:

Fangusaro, Jason;
Gururangan, Sridharan;
Poussaint, Tina Young;
McLendon, Roger E;
Onar-Thomas, Arzu;
Warren, Katherine E;
Wu, Shengjie;
Packer, Roger J;
Banerjee, Anu;
Gilbertson, Richard J;
Jakacki, Regina;
Gajjar, Amar;
Goldman, Stewart;
Pollack, Ian F;
Friedman, Henry S;
Boyett, James M;
Kun, Larry E;
Fouladi, Maryam

Publication type:

journal article

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11).

Published in:

Cancer (0008543X), 2013, v. 119, n. 23, p. 4180, doi. 10.1002/cncr.28343

By:

Fangusaro, Jason;
Gururangan, Sridharan;
Poussaint, Tina Young;
McLendon, Roger E.;
Onar‐Thomas, Arzu;
Warren, Katherine E.;
Wu, Shengjie;
Packer, Roger J.;
Banerjee, Anu;
Gilbertson, Richard J.;
Jakacki, Regina;
Gajjar, Amar;
Goldman, Stewart;
Pollack, Ian F.;
Friedman, Henry S.;
Boyett, James M.;
Kun, Larry E.;
Fouladi, Maryam

Publication type:

Article

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.

Published in:

Cancer (0008543X), 2012, v. 118, n. 19, p. 4759, doi. 10.1002/cncr.26541

By:

Reardon, David A.;
Desjardins, Annick;
Vredenburgh, James J.;
Herndon, James E.;
Coan, April;
Gururangan, Sridharan;
Peters, Katherine B.;
McLendon, Roger;
Sathornsumetee, Sith;
Rich, Jeremy N.;
Lipp, Eric S.;
Janney, Dorothea;
Friedman, Henry S.

Publication type:

Article

Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.

Published in:

Cancer (0008543X), 2011, v. 117, n. 23, p. 5351, doi. 10.1002/cncr.26188

By:

Reardon, David A.;
Desjardins, Annick;
Peters, Katherine B.;
Vredenburgh, James J.;
Gururangan, Sridharan;
Sampson, John H.;
McLendon, Roger E.;
Herndon, James E.;
Coan, April;
Threatt, Stevie;
Friedman, Allan H.;
Friedman, Henry S.

Publication type:

Article

Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.

Published in:

2009

By:

Quinn JA;
Jiang SX;
Reardon DA;
Desjardins A;
Vredenburgh JJ;
Gururangan S;
Sampson JH;
McLendon RE;
Herndon JE 2nd;
Friedman HS;
Quinn, Jennifer A;
Jiang, Sara Xiaoyin;
Reardon, David A;
Desjardins, Annick;
Vredenburgh, James J;
Gururangan, Sridharan;
Sampson, John H;
McLendon, Roger E;
Herndon, James E 2nd;
Friedman, Henry S

Publication type:

journal article

Phase 1 Trial of Temozolomide Plus Irinotecan Plus O6-Benzylguanine in Adults With Recurrent Malignant Glioma.

Published in:

Cancer (0008543X), 2009, v. 115, n. 13, p. 2964, doi. 10.1002/cncr.24336

By:

Quinn, Jennifer A.;
Jiang, Sara Xiaoyin;
Reardon, David A.;
Desjardins, Annick;
Vredenburgh, James J.;
Gururangan, Sridharan;
Sampson, John H.;
McLendon, Roger E.;
Herndon II, James E.;
Friedman, Henry S.

Publication type:

Article

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.

Published in:

2009

By:

Reardon DA;
Egorin MJ;
Desjardins A;
Vredenburgh JJ;
Beumer JH;
Lagattuta TF;
Gururangan S;
Herndon JE 2nd;
Salvado AJ;
Friedman HS;
Reardon, David A;
Egorin, Merrill J;
Desjardins, Annick;
Vredenburgh, James J;
Beumer, Jan H;
Lagattuta, Theodore F;
Gururangan, Sridharan;
Herndon, James E 2nd;
Salvado, August J;
Friedman, Henry S

Publication type:

journal article

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042).

Published in:

Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28879

By:

Van Mater, David;
Gururangan, Sridharan;
Becher, Oren;
Campagne, Olivia;
Leary, Sarah;
Phillips, Joanna J.;
Huang, Jie;
Lin, Tong;
Poussaint, Tina Young;
Goldman, Stewart;
Baxter, Patricia;
Dhall, Girish;
Robinson, Giles;
DeWire‐Schottmiller, Mariko;
Hwang, Eugene I.;
Stewart, Clinton F.;
Onar‐Thomas, Arzu;
Dunkel, Ira J.;
Fouladi, Maryam

Publication type:

Article

Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab.

Published in:

2019

By:

Müller, Hermann L.;
Merks, Johannes H.M.;
Geoerger, Birgit;
Grill, Jacques;
Hargrave, Darren;
Glade Bender, Julia;
Gururangan, Sridharan;
Navid, Fariba;
Johnston, Michael;
Bachir, Jeanette;
Elze, Markus C.;
Fürst‐Recktenwald, Sabine;
Fürst-Recktenwald, Sabine

Publication type:

journal article

Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.

Published in:

Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1855, doi. 10.1002/pbc.25560

By:

Gururangan, Sridharan;
Robinson, Giles;
Ellison, David W.;
Wu, Gang;
He, Xuelian;
Lu, Q. Richard;
McLendon, Roger;
Grant, Gerald;
Driscoll, Timothy;
Neuberg, Ronnie

Publication type:

Article

Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Published in:

2014

By:

Bass, Johnnie K;
Huang, Jie;
Onar-Thomas, Arzu;
Chang, Kay W;
Bhagat, Shaum P;
Chintagumpala, Murali;
Bartels, Ute;
Gururangan, Sridharan;
Hassall, Tim;
Heath, John A;
McCowage, Geoffrey;
Cohn, Richard J;
Fisher, Michael J;
Robinson, Giles;
Broniscer, Alberto;
Gajjar, Amar;
Gurney, James G

Publication type:

journal article

Concordance between the chang and the International Society of Pediatric Oncology ( SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Published in:

Pediatric Blood & Cancer, 2014, v. 61, n. 4, p. 601, doi. 10.1002/pbc.24830

By:

Bass, Johnnie K.;
Huang, Jie;
Onar ‐ Thomas, Arzu;
Chang, Kay W.;
Bhagat, Shaum P.;
Chintagumpala, Murali;
Bartels, Ute;
Gururangan, Sridharan;
Hassall, Tim;
Heath, John A.;
McCowage, Geoffrey;
Cohn, Richard J.;
Fisher, Michael J.;
Robinson, Giles;
Broniscer, Alberto;
Gajjar, Amar;
Gurney, James G.

Publication type:

Article

Non-cerebellar primitive neuroectodermal tumors (PNET): Summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.

Published in:

Pediatric Blood & Cancer, 2010, v. 54, n. 4, p. 638, doi. 10.1002/pbc.22373

By:

Fangusaro, Jason;
Massimino, Maura;
Rutkowski, Stefan;
Gururangan, Sridharan

Publication type:

Article

Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program.

Published in:

2008

By:

Keir ST;
Morton CL;
Billups C;
Smith MA;
Houghton PJ;
Gururangan S;
Keir, Stephen T;
Morton, Christopher L;
Billups, Catherine;
Smith, Malcolm A;
Houghton, Peter J;
Gururangan, Sridharan

Publication type:

journal article

Initial testing of VNP40101M (Cloretazine®) by the pediatric preclinical testing program.

Published in:

Pediatric Blood & Cancer, 2008, v. 51, n. 3, p. 439, doi. 10.1002/pbc.21620

By:

Keir, Stephen T.;
Morton, Christopher L.;
Billups, Catherine;
Smith, Malcolm A.;
Houghton, Peter J.;
Gururangan, Sridharan

Publication type:

Article

Intracranial Ewing sarcoma.

Published in:

Pediatric Blood & Cancer, 2005, v. 45, n. 6, p. 850, doi. 10.1002/pbc.20430

By:

Mazur, Melissa A.;
Gururangan, Sridharan;
Bridge, Julia A.;
Cummings, Thomas J.;
Mukundan, Srinivasan;
Fuchs, Herbert;
Larrier, Nicole;
Halperin, Edward C.

Publication type:

Article

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Published in:

Child's Nervous System, 2015, v. 31, n. 8, p. 1283, doi. 10.1007/s00381-015-2725-3

By:

Hoffman, Lindsey;
Fouladi, Maryam;
Olson, James;
Daryani, Vinay;
Stewart, Clinton;
Wetmore, Cynthia;
Kocak, Mehmet;
Onar-Thomas, Arzu;
Wagner, Lars;
Gururangan, Sridharan;
Packer, Roger;
Blaney, Susan;
Gajjar, Amar;
Kun, Larry;
Boyett, James;
Gilbertson, Richard

Publication type:

Article

Additional Evidence of a Nonverbal Learning Disability in Survivors of Pediatric Brain Tumors.

Published in:

Children's Health Care, 2009, v. 38, n. 1, p. 49, doi. 10.1080/02739610802615849

By:

Bonner, MelanieJ.;
Hardy, KristinaK.;
Willard, VictoriaW.;
Gururangan, Sridharan

Publication type:

Article

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.

Published in:

2005

By:

Reardon, David A;
Quinn, Jennifer A;
Rich, Jeremy N;
Desjardins, Annick;
Vredenburgh, James;
Gururangan, Sridharan;
Sathornsumetee, Sith;
Badruddoja, Michael;
McLendon, Roger;
Provenzale, James;
Herndon, James E 2nd;
Dowell, Jeannette M;
Burkart, Jill L;
Newton, Herbert B;
Friedman, Allan H;
Friedman, Henry S

Publication type:

journal article

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.

Published in:

Cancer (0008543X), 2005, v. 104, n. 7, p. 1478, doi. 10.1002/cncr.21316

By:

David A. Reardon;
Jennifer A. Quinn;
Jeremy N. Rich;
Annick Desjardins;
James Vredenburgh;
Sridharan Gururangan;
Sith Sathornsumetee;
Michael Badruddoja;
Roger McLendon;
James Provenzale;
James E. Herndon;
Jeannette M. Dowell;
Jill L. Burkart;
Herbert B. Newton;
Allan H. Friedman;
Henry S. Friedman

Publication type:

Article

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.

Published in:

2005

By:

Reardon, David A;
Quinn, Jennifer A;
Vredenburgh, James;
Rich, Jeremy N;
Gururangan, Sridharan;
Badruddoja, Michael;
Herndon, James E 2nd;
Dowell, Jeannette M;
Friedman, Allan H;
Friedman, Henry S

Publication type:

journal article

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.

Published in:

Cancer (0008543X), 2005, v. 103, n. 2, p. 329

By:

David A. Reardon;
Jennifer A. Quinn;
James Vredenburgh;
Jeremy N. Rich;
Sridharan Gururangan;
Michael Badruddoja;
James E. Herndon;
Jeannette M. Dowell;
Allan H. Friedman;
Henry S. Friedman

Publication type:

Article

High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.

Published in:

Human Genetics, 2007, v. 122, n. 2, p. 117, doi. 10.1007/s00439-007-0386-3

By:

Jackson, Eric;
Shaikh, Tamim;
Gururangan, Sridharan;
Jones, Marilyn;
Malkin, David;
Nikkel, Sarah;
Zuppan, Craig;
Wainwright, Luanne;
Zhang, Fan;
Biegel, Jaclyn

Publication type:

Article

Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 8, p. 1237, doi. 10.2967/jnumed.112.115782

By:

Zukotynski, Katherine A.;
Fahey, Frederic H.;
Vajapeyam, Sridhar;
Ng, Sarah S.;
Kocak, Mehmet;
Gururangan, Sridharan;
Kun, Larry E.;
Poussaint, Tina Y.

Publication type:

Article

Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with 131I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 912

By:

Reardon, David A.;
Quinn, Jennifer A.;
Akabani, Gamal;
Coleman, R. Edward;
Friedman, Allan H.;
Friedman, Henry S.;
Herndon II, James E.;
McLendon, Roger E.;
Pegram, Charles N.;
Provenzale, James M.;
Dowell, Jeannette M.;
Rich, Jeremy N.;
Vredenburgh, James J.;
Desjardins, Annick;
Sampson, John H.;
Gururangan, Sridharan;
Wong, Terence Z.;
Badruddoja, Michael A.;
Xiao-Guang Zhao;
Bigner, Darell D.

Publication type:

Article

Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Published in:

2021

By:

Liu, I-Chia;
Holtzman, Adam L.;
Rotondo, Ronny L.;
Indelicato, Daniel J.;
Gururangan, Sridharan;
Cavaliere, Robert;
Carter, Bridgette;
Morris, Christopher G.;
Tavanaiepour, Daryoush;
Rutenberg, Michael S.

Publication type:

Correction Notice

Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Published in:

Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 467, doi. 10.1007/s11060-021-03783-x

By:

Liu, I-Chia;
Holtzman, Adam L.;
Rotondo, Ronny L.;
Indelicato, Daniel J.;
Gururangan, Sridharan;
Cavaliere, Robert;
Carter, Bridgette;
Morris, Christopher G.;
Tavanaiepour, Daryoush;
Rutenberg, Michael S.

Publication type:

Article

The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 1, p. 83, doi. 10.1007/s11060-016-2338-z

By:

Thompson, Eric;
Gururangan, Sridharan;
Grant, Gerald;
Mitchell, Duane;
Sampson, John

Publication type:

Article

Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.

Published in:

Journal of Neuro-Oncology, 2015, v. 125, n. 1, p. 65, doi. 10.1007/s11060-015-1890-2

By:

Nair, Smita;
Driscoll, Timothy;
Boczkowski, David;
Schmittling, Robert;
Reynolds, Renee;
Johnson, Laura;
Grant, Gerald;
Fuchs, Herbert;
Bigner, Darell;
Sampson, John;
Gururangan, Sridharan;
Mitchell, Duane

Publication type:

Article

Sluggish cognitive tempo in survivors of pediatric brain tumors.

Published in:

Journal of Neuro-Oncology, 2013, v. 114, n. 1, p. 71, doi. 10.1007/s11060-013-1149-8

By:

Willard, Victoria;
Hardy, Kristina;
Allen, Taryn;
Hwang, Eugene;
Gururangan, Sridharan;
Hostetter, Sarah;
Bonner, Melanie

Publication type:

Article

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 155, doi. 10.1007/s11060-011-0722-2

By:

Reardon, David;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
McLendon, Roger;
Herndon, James;
Bulusu, Anuradha;
Threatt, Stevie;
Friedman, Allan;
Vredenburgh, James;
Friedman, Henry

Publication type:

Article

Phase II study of Gleevec plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.

Published in:

Journal of Neuro-Oncology, 2012, v. 106, n. 2, p. 409, doi. 10.1007/s11060-011-0687-1

By:

Reardon, David;
Norden, Andrew;
Desjardins, Annick;
Vredenburgh, James;
Herndon, James;
Coan, April;
Sampson, John;
Gururangan, Sridharan;
Peters, Katherine;
McLendon, Roger;
Norfleet, Julie;
Lipp, Eric;
Drappatz, Jan;
Wen, Patrick;
Friedman, Henry

Publication type:

Article

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 621, doi. 10.1007/s11060-011-0631-4

By:

Reardon, David;
Vredenburgh, James;
Coan, April;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sathornsumetee, Sith;
Rich, Jeremy;
Herndon, James;
Friedman, Henry

Publication type:

Article

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.

Published in:

Journal of Neuro-Oncology, 2011, v. 103, n. 2, p. 371, doi. 10.1007/s11060-010-0403-6

By:

Reardon, David;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
Rich, Jeremy;
McLendon, Roger;
Herndon, James;
Marcello, Jennifer;
Threatt, Stevie;
Friedman, Allan;
Vredenburgh, James;
Friedman, Henry

Publication type:

Article

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2011, v. 101, n. 1, p. 57, doi. 10.1007/s11060-010-0217-6

By:

Reardon, David;
Vredenburgh, James;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
Marcello, Jennifer;
Herndon, James;
McLendon, Roger;
Janney, Dorothea;
Friedman, Allan;
Bigner, Darell;
Friedman, Henry

Publication type:

Article

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2010, v. 96, n. 2, p. 219, doi. 10.1007/s11060-009-9950-0

By:

Reardon, David;
Desjardins, Annick;
Vredenburgh, James;
Gururangan, Sridharan;
Friedman, Allan;
Herndon, James;
Marcello, Jennifer;
Norfleet, Julie;
McLendon, Roger;
Sampson, John;
Friedman, Henry

Publication type:

Article

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2007, v. 83, n. 1, p. 53, doi. 10.1007/s11060-006-9302-2

By:

Annick Desjardins;
Jennifer Quinn;
James Vredenburgh;
Sith Sathornsumetee;
Allan Friedman;
James Herndon;
Roger McLendon;
James Provenzale;
Jeremy Rich;
John Sampson;
Sridharan Gururangan;
Jeannette Dowell;
August Salvado

Publication type:

Article

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 81, n. 1, p. 148, doi. 10.1111/bcp.12778

By:

Han, Kelong;
Peyret, Thomas;
Quartino, Angelica;
Gosselin, Nathalie H.;
Gururangan, Sridharan;
Casanova, Michela;
Merks, Johannes H. M.;
Massimino, Maura;
Grill, Jacques;
Daw, Najat C.;
Navid, Fariba;
Jin, Jin;
Allison, David E.

Publication type:

Article

Acute neurotoxicity following vincristine due to Charcot–Marie–Tooth disease in a young child with medulloblastoma.

Published in:

Neuro-Oncology Practice, 2019, v. 6, n. 3, p. 179, doi. 10.1093/nop/npz002

By:

Kissoon, Trisha;
Gururangan, Sridharan;
Sladky, John

Publication type:

Article

Social Functioning and Facial Expression Recognition in Survivors of Pediatric Brain Tumors.

Published in:

Journal of Pediatric Psychology, 2008, v. 33, n. 10, p. 1142, doi. 10.1093/jpepsy/jsn035

By:

Bonner, Melanie J.;
Hardy, Kristina K.;
Willard, Victoria W.;
Anthony, Kelly K.;
Hood, Maggie;
Gururangan, Sridharan

Publication type:

Article

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.

Published in:

Acta Neuropathologica, 2020, v. 139, n. 2, p. 223, doi. 10.1007/s00401-019-02111-y

By:

Li, Bryan K.;
Vasiljevic, Alexandre;
Dufour, Christelle;
Yao, Fupan;
Ho, Ben L. B.;
Lu, Mei;
Hwang, Eugene I.;
Gururangan, Sridharan;
Hansford, Jordan R.;
Fouladi, Maryam;
Nobusawa, Sumihito;
Laquerriere, Annie;
Delisle, Marie-Bernadette;
Fangusaro, Jason;
Forest, Fabien;
Toledano, Helen;
Solano-Paez, Palma;
Leary, Sarah;
Birks, Diane;
Hoffman, Lindsey M.

Publication type:

Article

Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Published in:

2020

By:

Liu, Anthony P. Y.;
Gudenas, Brian;
Lin, Tong;
Orr, Brent A.;
Klimo, Paul;
Kumar, Rahul;
Bouffet, Eric;
Gururangan, Sridharan;
Crawford, John R.;
Kellie, Stewart J.;
Chintagumpala, Murali;
Fisher, Michael J.;
Bowers, Daniel C.;
Hassall, Tim;
Indelicato, Daniel J.;
Onar-Thomas, Arzu;
Ellison, David W.;
Boop, Frederick A.;
Merchant, Thomas E.;
Robinson, Giles W.

Publication type:

Correction Notice

Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Published in:

Acta Neuropathologica, 2020, v. 139, n. 2, p. 259, doi. 10.1007/s00401-019-02106-9

By:

Liu, Anthony P. Y.;
Gudenas, Brian;
Lin, Tong;
Orr, Brent A.;
Klimo, Paul;
Kumar, Rahul;
Bouffet, Eric;
Gururangan, Sridharan;
Crawford, John R.;
Kellie, Stewart J.;
Chintagumpala, Murali;
Fisher, Michael J.;
Bowers, Daniel C.;
Hassall, Tim;
Indelicato, Daniel J.;
Onar-Thomas, Arzu;
Ellison, David W.;
Boop, Frederick A.;
Merchant, Thomas E.;
Robinson, Giles W.

Publication type:

Article

Heterogeneity within the PF-EPN-B ependymoma subgroup.

Published in:

Acta Neuropathologica, 2018, v. 136, n. 2, p. 227, doi. 10.1007/s00401-018-1888-x

By:

Cavalli, Florence M. G.;
Hübner, Jens-Martin;
Sharma, Tanvi;
Luu, Betty;
Sill, Martin;
Zapotocky, Michal;
Mack, Stephen C.;
Witt, Hendrik;
Lin, Tong;
Shih, David J. H.;
Ho, Ben;
Santi, Mariarita;
Emery, Lyndsey;
Hukin, Juliette;
Dunham, Christopher;
McLendon, Roger E.;
Lipp, Eric S.;
Gururangan, Sridharan;
Grossbach, Andrew;
French, Pim

Publication type:

Article

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908.

Published in:

Neuro-Oncology, 2023, v. 25, n. 8, p. 1530, doi. 10.1093/neuonc/noad031

By:

Dunkel, Ira J;
Doz, François;
Foreman, Nicholas K;
Hargrave, Darren;
Lassaletta, Alvaro;
André, Nicolas;
Hansford, Jordan R;
Hassall, Tim;
Eyrich, Matthias;
Gururangan, Sridharan;
Bartels, Ute;
Gajjar, Amar;
Howell, Lisa;
Warad, Deepti;
Pacius, Misena;
Tam, Rachel;
Wang, Yu;
Zhu, Li;
Cohen, Kenneth

Publication type:

Article

Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.

Published in:

Neuro-Oncology, 2022, v. 24, n. 1, p. 141, doi. 10.1093/neuonc/noab140

By:

Erker, Craig;
Lane, Adam;
Chaney, Brooklyn;
Leary, Sarah;
Minturn, Jane E;
Bartels, Ute;
Packer, Roger J;
Dorris, Kathleen;
Gottardo, Nicholas G;
Warren, Katherine E;
Broniscer, Alberto;
Kieran, Mark W;
Zhu, Xiaoting;
White, Peter;
Dexheimer, Phillip J;
Black, Katie;
Asher, Anthony;
DeWire, Mariko;
Hansford, Jordan R;
Gururangan, Sridharan

Publication type:

Article